Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB ‐amplified renal cell carcinoma: a comprehensive study of 15 cases
Histopathology · 2026-12 · 89 (6) · 1083-1094
DOI: 10.1111/his.70261 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Histopathology, online erschienen am 13.08.2026. Verfasst von Hayley Zullow und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Eosinophilic solid and cystic renal cell carcinoma (ESC‐RCC) and TFEB ‐amplified renal cell carcinoma ( TFEB ‐amplified RCC, a subset of TFEB‐ altered RCC) are rare eosinophilic renal cell tumours that can be difficult to distinguish on the basis of morphology and immunohistochemistry alone. In this study, we compared the clinicopathological and molecular features of these entities to identify distinguishing characteristics. Methods and results Nine cases of ESC‐RCC and six cases of TFEB ‐amplified RCC from our institutional archives were evaluated for clinical, morphological, immunohistochemical and molecular features. Despite morphological overlap, each entity exhibited somewhat distinctive features. ESC‐RCC frequently exhibited solid and cystic architecture with tightly packed tubules, flocculent to coarsely granular cytoplasm with basophilic stippling and prominent admixed macrophages. In comparison, TFEB ‐amplified RCC more frequently demonstrated solid growth of pseudopapillae and loose tubules, dense eosinophilic granular cytoplasm without basophilic stippling, focally apical nuclei and extracellular magenta globules. However, neither morphology nor immunohistochemistry was sufficiently specific to completely distinguish these entities. Ancillary molecular testing identified pathogenic TSC1 or TSC2 gene variants in ESC‐RCC and TFEB gene locus amplification in TFEB ‐amplified RCC.
Conclusions
Although ESC‐RCC and TFEB ‐RCC share overlapping morphological and immunohistochemical features, each demonstrates somewhat characteristic histological findings. Definitive distinction requires molecular testing to identify the underlying molecular alterations. As molecular testing assumes an increasingly important role in RCC diagnosis and classification, recognition of these rare entities and their overlapping and distinguishing features is essential for appropriate testing and accurate diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The University of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Hayley Zullow, Melissa Y Tjota, Jung Woo Kwon, Tatjana Antic
Zitieren
APA
Zullow, H., Tjota, M. Y., Kwon, J. W., & Antic, T. (2026). Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB ‐amplified renal cell carcinoma: a comprehensive study of 15 cases. Histopathology, 89(6), 1083-1094. https://doi.org/10.1111/his.70261
Vancouver
Zullow H, Tjota MY, Kwon JW, Antic T. Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB ‐amplified renal cell carcinoma: a comprehensive study of 15 cases. Histopathology. 2026;89(6):1083-1094. doi:10.1111/his.70261
BibTeX
@article{Zullow2026,
author = {Zullow, Hayley and Tjota, Melissa Y and Kwon, Jung Woo and Antic, Tatjana},
title = {Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB ‐amplified renal cell carcinoma: a comprehensive study of 15 cases},
journal = {Histopathology},
year = {2026},
volume = {89},
number = {6},
pages = {1083--1094},
doi = {10.1111/his.70261}
}
EUVIMED